Selio is a simple, effective, and patent-protected technology. The Selio prototype has been rigorously tested in the lab and in subsequent acute pre-clinical in vivo studies with very positive results.
Selio Medical adopts a unique approach by preventing the pneumothorax from occurring before the biopsy even takes place.
The Selio System™ is a single-use, prophylactic device, comprising a smart delivery needle together with a biodegradable hydrogel sealant.
Our proven technology seamlessly integrates with the current standard of care and enables the clinician to pre-seal the access route into the lung before the biopsy.
The Selio System™ allows the patient to safely return home on the same day as their procedure. This significantly improves the patient’s quality of care while preventing further treatment and costs.
technology, pre-clinical, prophylactic device
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Selio Medical? We’re happy to assist you with our Startup Sourcing service.